Literature DB >> 14581761

Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases.

Toshifumi Ohkusa1, Hiroto Miwa, Mariko Hojo, Jiro Kumagai, Toru Tanizawa, Daisuke Asaoka, Takeshi Terai, Ryuichi Ohkura, Nobuhiro Sato.   

Abstract

BACKGROUND: Evidence indicates that eradication of Helicobacter pylori leads to the disappearance of hyperplastic polyps in the stomach. However, there are some exceptions. We have compared endoscopic and serologic findings of responder and non-responder cases with hyperplastic polyps to try to identify the cause(s), other than H. pylori infection, of the formation or growth of gastric hyperplastic polyps.
METHODS: We retrospectively studied 33 patients whose hyperplastic polyps disappeared after eradication of H. pylori and 10 patients whose hyperplastic polyps did not disappear after eradication. The patients were examined both endoscopically and serologically before, 1-3 months after and 12-15 months after the eradication.
RESULTS: The responder and non-responder groups were similar with respect to age, sex, coexisting diseases, and histologic findings. The number and maximum size of polyps tended to be larger before treatment in the non-responder group than in the responder group. The serum gastrin level was higher in the non-responder group than in the responder group before, 1-3 months after and 12-15 months after the eradication (p=0.0096, p>0.2, p=0.0014). On histologic examination, similar reductions in the degree of inflammatory cell infiltration in the gastric mucosa of the antrum and body were seen in both the responder and non-responder groups. In the non-responders, the size and numbers of the polyps regressed in 5 of the 10 patients. The score of glandular atrophy in the antrum and the serum gastrin levels in the non-regressed cases was higher than those in the regressed cases at 1-3 and 12-15 months after eradication.
CONCLUSION: Persistent high gastrin levels were found in the non-responder cases with gastric hyperplastic polyps. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14581761     DOI: 10.1159/000074516

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  12 in total

1.  Diagnostic accuracy of demarcation of undifferentiated-type early gastric cancer after Helicobacter pylori eradication.

Authors:  Yusuke Horiuchi; Junko Fujisaki; Noriko Yamamoto; Masami Omae; Akiyoshi Ishiyama; Toshiyuki Yoshio; Toshiaki Hirasawa; Yorimasa Yamamoto; Tomohiro Tsuchida; Hiroshi Takahashi
Journal:  J Gastroenterol       Date:  2017-01-12       Impact factor: 7.527

2.  Gastric polyps: a review of clinical, endoscopic, and histopathologic features and management decisions.

Authors:  Rafiul Sameer Islam; Neal C Patel; Dora Lam-Himlin; Cuong C Nguyen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-10

3.  Predictive findings for Helicobacter pylori-uninfected, -infected and -eradicated gastric mucosa: validation study.

Authors:  Kazuhiro Watanabe; Naoyoshi Nagata; Ryo Nakashima; Etsuko Furuhata; Takuro Shimbo; Masao Kobayakawa; Toshiyuki Sakurai; Koh Imbe; Ryota Niikura; Chizu Yokoi; Junichi Akiyama; Naomi Uemura
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

4.  Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.

Authors:  Hajime Anjiki; Ken-Ichi Mukaisho; Yu Kadomoto; Hisakazu Doi; Kunio Yoshikawa; Takahisa Nakayama; Diem Thi-Ngoc Vo; Takanori Hattori; Hiroyuki Sugihara
Journal:  Clin J Gastroenterol       Date:  2017-02-03

5.  British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.

Authors:  Matthew Banks; David Graham; Marnix Jansen; Takuji Gotoda; Sergio Coda; Massimiliano di Pietro; Noriya Uedo; Pradeep Bhandari; D Mark Pritchard; Ernst J Kuipers; Manuel Rodriguez-Justo; Marco R Novelli; Krish Ragunath; Neil Shepherd; Mario Dinis-Ribeiro
Journal:  Gut       Date:  2019-07-05       Impact factor: 23.059

6.  Endoscopic ultrasonographic assessment of gastric polyps and endoscopic mucosal resection.

Authors:  Brintha K Enestvedt; Vinay Chandrasekhara; Gregory G Ginsberg
Journal:  Curr Gastroenterol Rep       Date:  2012-12

7.  Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial.

Authors:  Su Youn Nam; Sang Won Lee; Seong Woo Jeon; Yong Hwan Kwon; Hyun Seok Lee
Journal:  Dig Dis Sci       Date:  2020-01-23       Impact factor: 3.199

Review 8.  Current Management of Benign Epithelial Gastric Polyps.

Authors:  Antonio R Cheesman; David A Greenwald; Shailja C Shah
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

9.  Endoscopic and histopathological features of the upper gastrointestinal system polyps: evaluation of 12.563 procedures.

Authors:  Hüseyin Çiyiltepe; Durmuş Ali Çetin; Ebubekir Gündeş; Ulaş Aday; Aziz Serkan Senger; Selçuk Gülmez; Sabiye Akbulut; Mustafa Duman
Journal:  Turk J Surg       Date:  2019-06-13

Review 10.  Gastritis, Gastric Polyps and Gastric Cancer.

Authors:  Helge Waldum; Reidar Fossmark
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.